Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Newmont (NEMCL) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Newmont (NEMCL) over the last 10 years, with Q3 2025 value amounting to -$99.0 million.

  • Newmont's Asset Writedowns and Impairment fell 18608.7% to -$99.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$806.0 million, marking a year-over-year decrease of 19527.19%. This contributed to the annual value of $1.1 billion for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Newmont's Asset Writedowns and Impairment stood at -$99.0 million, which was down 18608.7% from -$699.0 million recorded in Q2 2025.
  • Over the past 5 years, Newmont's Asset Writedowns and Impairment peaked at $571.0 million during Q3 2021, and registered a low of -$699.0 million during Q2 2025.
  • For the 3-year period, Newmont's Asset Writedowns and Impairment averaged around $76.4 million, with its median value being $180.5 million (2024).
  • The largest annual percentage gain for Newmont's Asset Writedowns and Impairment in the last 5 years was 15690.72% (2025), contrasted with its biggest fall of 38414.63% (2025).
  • Newmont's Asset Writedowns and Impairment (Quarter) stood at $571.0 million in 2021, then plummeted by 53.06% to $268.0 million in 2024, then crashed by 136.94% to -$99.0 million in 2025.
  • Its Asset Writedowns and Impairment was -$99.0 million in Q3 2025, compared to -$699.0 million in Q2 2025 and -$276.0 million in Q1 2025.